Delivery Order SPE2DB20D3103-SPE2DB24FP2G2
Award Date
6/18/24
Potential Completion Date
6/20/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,171.57 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Vial, 10mL. The contract has an ultimate completion date of August 23, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $6,139.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of insulin aspart 100 unit/mL in 10 mL vials. The contract is a firm fixed-price delivery order with a period of performance through May 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,463.20 fixed-price delivery order is for the supply of 4568200468 Insulin Aspart 100 Unit/mL Vials (10mL), with a performance period ending on May 12, 2025. The award is not associated with a set-aside program and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,582.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Aspart 100 Unit/ML Vial (10 ML), a critical medication for diabetes management. This contract is a delivery order awarded under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,443.60 firm fixed price delivery order is for the supply of Insulin Aspart 100 Unit/mL vials. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award, with a total ceiling value of $36,063.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Aspart 100 Unit/ML VL 10ML. The contract has a firm fixed price of $4,746.50 and a completion date of January 19, 2024. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical division. This IDC serves...
This federal contract award, valued at $3,013.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Aspart 100 Unit/mL medication, a critical pharmaceutical product used in the treatment of diabetes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $3,640.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Aspart 100 Unit/mL Vial 10mL, a type of insulin medication. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 7, 2025. This award is not designated as a set-aside contract. The contract is part of a larger...
This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL Vials (10 mL) to the Defense Logistics Agency (DLA). The contract, valued at $2,250.10, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 22, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...